Omnia Family Wealth LLC Acquires 112 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Omnia Family Wealth LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 14.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 894 shares of the healthcare conglomerate’s stock after purchasing an additional 112 shares during the quarter. Omnia Family Wealth LLC’s holdings in UnitedHealth Group were worth $523,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of UnitedHealth Group by 0.6% during the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of UnitedHealth Group by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after acquiring an additional 94,641 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after purchasing an additional 35,533 shares in the last quarter. International Assets Investment Management LLC increased its stake in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after buying an additional 880,183 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Bank of America reduced their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

Shares of UNH stock traded down $6.14 during trading hours on Thursday, reaching $599.73. The company’s stock had a trading volume of 605,900 shares, compared to its average volume of 3,879,608. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $551.92 billion, a price-to-earnings ratio of 39.47, a PEG ratio of 1.80 and a beta of 0.58. The firm’s 50 day simple moving average is $582.99 and its 200-day simple moving average is $548.03.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.56 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.